Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates Shana JacobsCynthia L. McCullyElizabeth Fox Original Article 07 August 2009 Pages: 817 - 824
Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases Hidekazu KuramochiKazuhiko HayashiPeter V. Danenberg Original Article 22 August 2009 Pages: 825 - 831
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors Yelena Y. JanjigianWooin LeeNaiyer A. Rizvi Original Article 12 August 2009 Pages: 833 - 838
Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression Emma K. HanssonJohan E. WallinLena E. Friberg Original Article 14 August 2009 Pages: 839 - 848
Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials Lidan LiuYunfei CaoFeng Gao Original Article 13 August 2009 Pages: 849 - 861
A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies Tanios Bekaii-SaabMarisa HillMiguel Villalona-Calero Original Article 06 August 2009 Pages: 863 - 869
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer Andrea RoccaRoberta MaltoniDino Amadori Original Article 20 August 2009 Pages: 871 - 876
Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol S. J. GreayD. J. IrelandC. F. Carson Original Article 13 August 2009 Pages: 877 - 888
Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors Takashi ShidaTakashi KishimotoMasaru Miyazaki Original Article 06 August 2009 Pages: 889 - 893
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo Ji-Hui DuHou-De ZhangKun-Mei Ji Original Article Open access 19 August 2009 Pages: 895 - 902
Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line Karnati R. RoyGorla V. ReddyPallu Reddanna Original Article 15 August 2009 Pages: 903 - 911
Optimization of the non-invasive 13C-sucrose breath test in a rat model of methotrexate-induced mucositis K. L. TooleyG. S. HowarthR. N. Butler Original Article 19 August 2009 Pages: 913 - 921
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane Zhongling FengGang ZhaoStephen B. Howell Original Article Open access 15 August 2009 Pages: 923 - 930
Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model Nohemí Salinas-JazmínMarisol de la FuenteMarco A. Velasco-Velázquez Original Article 19 August 2009 Pages: 931 - 940
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase Frederick H. HausheerDakshine ShanmugarajahAulma R. Parker Original Article 28 August 2009 Pages: 941 - 951
Co-administration of irinotecan decreases the plasma concentration of an active metabolite of amrubicin, amrubicinol in rats Yukiko MaedaAkinobu HamadaHideyuki Saito Original Article 21 August 2009 Pages: 953 - 959
Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate Akira SawakiYasuhide YamadaToshirou Nishida Original Article Open access 19 August 2009 Pages: 961 - 967
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy Rhys D. ClyburnPenny ReidIngunn Holen Original Article 03 September 2009 Pages: 969 - 978
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy Peter M. WilsonAnthony El-KhoueiryHeinz-Josef Lenz Clinical Trial Report 09 January 2010 Pages: 979 - 988
DNA damage induced by the anthracycline cosmomycin D in DNA repair-deficient cells Helotonio CarvalhoLeandro M. GarridoCarlos Frederico Martins Menck Short Communication 28 January 2010 Pages: 989 - 994
In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine Yong ChenLisa LiuSekhar Surapaneni Short Communication Open access 30 January 2010 Pages: 995 - 1000
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab Brett L. GourleyHector MesaPankaj Gupta Short Communication 30 January 2010 Pages: 1001 - 1004
